The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner
Open accessAbstract
Inflammatory bowel disease (IBD) is a global health problem in which gut microbiota dysbiosis plays an important pathogenic role.However, the current drugs for IBD treatment are far from optimal.Previous researches indicated that parthenolide (PTL) had not only anti-cancer properties but also strong anti-inflammatory activities.Rationale: To investigate the protective effect of PTL on colon inflammation and demonstrate the underlying gut microbiota-dependent mechanism.Methods: Colon inflammation severity in mouse model was measured by body weight change, mortality, colon length, disease activity index (DAI) score, H&E staining and colonoscopy evaluation.Gut microbiota alteration and short-chain fatty acids (SCFAs) production were analyzed through 16S rRNA sequencing and targeted metabolomics.Luminex cytokine microarray and Enzyme-linked immunosorbent assay (ELISA) were conducted to measure the colon cytokines profile.The frequency of immune cells in lamina propria (LP) and spleen were phenotyped by flow cytometry.Results: The PTL-treated mice showed significantly relieved colon inflammation, as evidenced by a reduction in body weight loss, survival rate, shortening of colon length, DAI score, histology score and colonoscopy score.Notably, when the gut microbiota was depleted using antibiotic cocktails, the protective effect of PTL on colon inflammation disappeared.PTL treatment downregulated the level of proinflammatory cytokines, including IL-1β, TNF-α, IL-6, and IL-17A and upregulated the immunosuppressive cytokine IL-10 in colon tissue.16S rRNA sequencing indicated that PTL-treated mice exhibited much more abundant gut microbial diversity and flora composition.Targeted metabolomics analysis manifested the increased SCFAs production in PTL-treated mice.Additionally, PTL administration selectively upregulated the frequency of colonic regulatory T (Treg) cells as well as downregulated the ratio of colonic T helper type 17 (Th17) cells, improving the Treg/Th17 balance to maintain intestinal homeostasis.Gut microbiota depletion and fecal microbiota transplantation (FMT) was performed to confirm this gut microbiota-dependent mechanism.Conclusions: PTL ameliorated colon inflammation in a gut microbiota-dependent manner.The underlying protective mechanism was associated with the improved Treg/Th17 balance in intestinal mucosa mediated through the increased microbiota-derived SCFAs production.Collectively, our results demonstrated the role of PTL as a potential gut microbiota modulator to prevent and treat IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice
Chassaing, B., Aitken, J. D., Malleshappa, M., & Vijay‐Kumar, M. (2014) · Current Protocols in Immunology · doi:10.1002/0471142735.im1525s104 · Cited by 2,090
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
Lavelle, A., & Sokol, H. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0258-z · Cited by 2,015
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Franzosa, E. A., Sirota-Madi, A., Avila-Pacheco, J., Fornelos, N., Haiser, H. J., Reinker, S., Vatanen, T., Hall, A. B., Mallick, H., McIver, L. J., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0306-4 · Cited by 1,995
Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904
Gut microbiota and IBD: causation or correlation?
Ni, J., Wu, G. D., Albenberg, L., & Tomov, V. T. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.88 · Cited by 1,778
Chemically induced mouse models of acute and chronic intestinal inflammation
Wirtz, S., Popp, V., Kindermann, M., Gerlach, K., Weigmann, B., Fichtner-Feigl, S., & Neurath, M. F. (2017) · Nature Protocols · doi:10.1038/nprot.2017.044 · Cited by 1,575
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Kaplan, G. G., & Ng, S. C. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.020 · Cited by 1,224
Dynamics of the human gut microbiome in inflammatory bowel disease
Halfvarson, J., Brislawn, C. J., Lamendella, R., Vázquez-Baeza, Y., Walters, W. A., Bramer, L. M., D'Amato, M., Bonfiglio, F., McDonald, D., Gonzalez, A., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.4 · Cited by 1,204
Current Understanding of Dysbiosis in Disease in Human and Animal Models
DeGruttola, A. K., Low, D., Mizoguchi, A., & Mizoguchi, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000750 · Cited by 1,122
The Balance of Th17 versus Treg Cells in Autoimmunity
Lee, G. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030730 · Cited by 857
Imhann, F., Vich Vila, A., Bonder, M. J., Fu, J., Gevers, D., Visschedijk, M. C., Spekhorst, L. M., Alberts, R., Franke, L., van Dullemen, H. M., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-312135 · Cited by 788
Wu, T.-R., Lin, C.-S., Chang, C.-J., Lin, T.-L., Martel, J., Ko, Y.-F., Ojcius, D. M., Lu, C.-C., Young, J. D., & Lai, H.-C. (2019) · Gut · doi:10.1136/gutjnl-2017-315458 · Cited by 758
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Wu, J. C., Chan, F. K., Sung, J. J., & Kaplan, G. (2017) · Gastroenterology · doi:10.1016/s0016-5085(17)33292-4 · Cited by 675
Tyagi, A. M., Yu, M., Darby, T. M., Vaccaro, C., Li, J.-Y., Owens, J. A., Hsu, E., Adams, J., Weitzmann, M. N., Jones, R. M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.10.013 · Cited by 564
Britton, G. J., Contijoch, E. J., Mogno, I., Vennaro, O. H., Llewellyn, S. R., Ng, R., Li, Z., Mortha, A., Merad, M., Das, A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.015 · Cited by 549
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice
Meira, L. B., Bugni, J. M., Green, S. L., Lee, C.-W., Pang, B., Borenshtein, D., Rickman, B. H., Rogers, A. B., Moroski-Erkul, C. A., McFaline, J. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35073 · Cited by 548
Allen, I. C., Wilson, J. E., Schneider, M., Lich, J. D., Roberts, R. A., Arthur, J. C., Woodford, R.-M. T., Davis, B. K., Uronis, J. M., Herfarth, H. H., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.012 · Cited by 534
The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome
Omenetti, S., & Pizarro, T. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00639 · Cited by 528
Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation
Gregory, J. C., Buffa, J. A., Org, E., Wang, Z., Levison, B. S., Zhu, W., Wagner, M. A., Bennett, B. J., Li, L., DiDonato, J. A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.618249 · Cited by 486
Developmental plasticity of Th17 and Treg cells
Lee, Y. K., Mukasa, R., Hatton, R. D., & Weaver, C. T. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.021 · Cited by 423
Richard, M. L., & Sokol, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0121-2 · Cited by 406
The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models
Nell, S., Suerbaum, S., & Josenhans, C. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2403 · Cited by 398
Gonçalves, P., Araújo, J. R., & Di Santo, J. P. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx029 · Cited by 393
The plasticity of human Treg and Th17 cells and its role in autoimmunity
Kleinewietfeld, M., & Hafler, D. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.009 · Cited by 389
Kelly, T. N., Bazzano, L. A., Ajami, N. J., He, H., Zhao, J., Petrosino, J. F., Correa, A., & He, J. (2016) · Circulation Research · doi:10.1161/circresaha.116.309219 · Cited by 345
Hovhannisyan, Z., Treatman, J., Littman, D. R., & Mayer, L. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.002 · Cited by 339
Role of Th17 Cells in the Pathogenesis of Human IBD
Gálvez, J. (2014) · ISRN Inflammation · doi:10.1155/2014/928461 · Cited by 319
Anhê, F. F., Nachbar, R. T., Varin, T. V., Trottier, J., Dudonné, S., Le Barz, M., Feutry, P., Pilon, G., Barbier, O., Desjardins, Y., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-315565 · Cited by 267
Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota
Wei, X., Tao, J., Xiao, S., Jiang, S., Shang, E., Zhu, Z., Qian, D., & Duan, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22094-2 · Cited by 256
Mathema, V. B., Koh, Y.-S., Thakuri, B. C., & Sillanpää, M. (2012) · Inflammation · doi:10.1007/s10753-011-9346-0 · Cited by 250
Downes, J., Dewhirst, F. E., Tanner, A. C. R., & Wade, W. G. (2013) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.041376-0 · Cited by 234
Advances in chemistry and bioactivity of parthenolide
Freund, R. R. A., Gobrecht, P., Fischer, D., & Arndt, H.-D. (2020) · Natural Product Reports · doi:10.1039/c9np00049f · Cited by 188
Dextran Sodium Sulfate-Induced Colitis in Germ-Free IQI/Jic Mice.
KITAJIMA, S., MORIMOTO, M., SAGARA, E., SHIMIZU, C., & IKEDA, Y. (2001) · Experimental Animals · doi:10.1538/expanim.50.387 · Cited by 167
Regulatory T-cell therapy in Crohn’s disease: challenges and advances
Clough, J. N., Omer, O. S., Tasker, S., Lord, G. M., & Irving, P. M. (2020) · Gut · doi:10.1136/gutjnl-2019-319850 · Cited by 160
Yu, R., Zuo, F., Ma, H., & Chen, S. (2019) · Nutrients · doi:10.3390/nu11040782 · Cited by 110
Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches
Hansen, J. J., & Sartor, R. B. (2015) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0042-7 · Cited by 109
Shi, L., Sheng, J., Wang, M., Luo, H., Zhu, J., Zhang, B., Liu, Z., & Yang, X. (2019) · Theranostics · doi:10.7150/thno.35131 · Cited by 107
Parthenolide could become a promising and stable drug with anti-inflammatory effects
Wang, M., & Li, Q. (2014) · Natural Product Research · doi:10.1080/14786419.2014.981541 · Cited by 58
Cao, Q., Gao, X., Lin, Y., Yue, C., Wang, Y., Quan, F., Zhang, Z., Liu, X., Lu, Y., Zhan, Y., et al. (2019) · Theranostics · doi:10.7150/thno.35015 · Cited by 58
Togo, A. H., Durand, G. A., Khelaifia, S., Armstrong, N., Robert, C., Cadoret, F., Pinto, F. D., Delerce, J., Levasseur, A., Raoult, D., et al. (2017) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.001826 · Cited by 44
Ren, Y., Li, Y., Lv, J., Guo, X., Zhang, J., Zhou, D., Zhang, Z., Xue, Z., Yang, G., Xi, Q., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28839 · Cited by 36
Cited by
Blevins, H. M., Xu, Y., Biby, S., & Zhang, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879021 · Cited by 587
Tong, L., Hao, H., Zhang, Z., Lv, Y., Liang, X., Liu, Q., Liu, T., Gong, P., Zhang, L., Cao, F., et al. (2021) · Theranostics · doi:10.7150/thno.62046 · Cited by 325
Anhê, F. F., Nachbar, R. T., Varin, T. V., Trottier, J., Dudonné, S., Le Barz, M., Feutry, P., Pilon, G., Barbier, O., Desjardins, Y., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-315565 · Cited by 267
Ge, L., Liu, S., Li, S., Yang, J., Hu, G., Xu, C., & Song, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016578 · Cited by 187
Self-citationWang, M., Zhou, B., Cong, W., Zhang, M., Li, Z., Li, Y., Liang, S., Chen, K., Yang, D., & Wu, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.797605 · Cited by 71
Metadata
- Authors
- Liu, Y.-J., Tang, B., Wang, F.-C., Tang, L., Lei, Y.-Y., Luo, Y., Huang, S.-J., Yang, M., Wu, L.-Y., Wang, W., Liu, S., Yang, S.-M., & Zhao, X.-Y.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2020
- Volume
- 10
- Issue
- 12
- Pages
- 5225-5241
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W3015217980
- Cited by
- 344
- References
- 45
- FWCI
- 16.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.